Stockscreener 앱 받기
28.46
1.52%
0.4781
전일 마감가:
$27.98
열려 있는:
$27.86
하루 거래량:
91,287
Relative Volume:
0.12
시가총액:
$1.39B
수익:
$458.69M
순이익/손실:
$11.68M
주가수익비율:
118.48
EPS:
0.2402
순현금흐름:
$14.58M
1주 성능:
-2.52%
1개월 성능:
+13.89%
6개월 성능:
-25.90%
1년 성능:
-34.16%
1일 변동 폭
$27.82
$28.55
1주일 범위
$27.77
$30.14
52주 변동 폭
$19.16
$48.25
Artivion Inc Stock (AORT) Company Profile
명칭
Artivion Inc
전화
(770) 419-3355
주소
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
28.46 | 1.41B | 458.69M | 11.68M | 14.58M | 0.2402 |
ABT
Abbott Laboratories
|
116.29 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.77 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
93.28 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.78 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.91 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-10 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2025-08-13 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | 개시 | Canaccord Genuity | Buy |
| 2024-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-27 | 재확인 | Lake Street | Buy |
| 2022-08-08 | 개시 | Lake Street | Buy |
| 2022-03-03 | 개시 | Stifel | Buy |
모두보기
Artivion Inc 주식(AORT)의 최신 뉴스
Artivion CEO James P. Mackin Sells 70,000 Shares of Common Stock at $28.955 Average Price - Kalkine Media
Artivion Inc (AORT) President & CEO James Mackin Sells 70,000 Sh - GuruFocus
Insider Selling: Artivion (NYSE:AORT) CEO Sells $2,026,500.00 in Stock - MarketBeat
Artivion (AORT) Results Review: EPS Falls Short of Its Estimate at the Close; After Results: The Stock Ends Down 0.28% in the Latest ReadingFinancial Summary - Vinanet
Artivion (AORT) Q2 2026 Earnings Call Transcript - AOL.com
Does Revenue Growth Amid New Losses Reshape The Bull Case For Artivion (AORT)? - simplywall.st
Why Artivion (AORT) Stock Is Trading Up Today - Yahoo Finance
Artivion (NASDAQ: AORT) executive moves to sell 70,000 shares - Stock Titan
Summit Creek Advisors LLC Takes Position in Artivion, Inc. $AORT - MarketBeat
Artivion (NYSE:AORT) Stock Price Up 5.7%Still a Buy? - MarketBeat
Canaccord raises Artivion stock price target to $40 on model update - Investing.com
Artivion CFO Lance A. Berry Sells 715 Shares to Cover RSU Tax Withholding - Kalkine Media
Artivion Inc. (AORT) Slides 2.8% to $28.32: Key Support Levels in FocusLow Vol Factor - Vinanet
Artivion EVP, COO, CFO & treasurer Berry sells $20,412 in stock - Investing.com Nigeria
Artivion SVP Andrew Green sells $17,586 of common stock - Investing.com
Artivion SVP Andrew Green sells $17,586 of common stock By Investing.com - Investing.com Canada
Artivion (NYSE: AORT) exec’s 616-share sale is tax-driven - Stock Titan
Artivion (AORT) Declines 1.82% to $28.61, Testing Key Support ZoneDollar Neutral Pair - Vinanet
Artivion (AORT) Edges Lower to $28.89 as Range-Bound Trading PersistsWyckoff Upthrust - Vinanet
5 Revealing Analyst Questions From Artivion’s Q2 Earnings Call - Yahoo Finance
Royal Bank of Canada Purchases 39,553 Shares of Artivion, Inc. $AORT - MarketBeat
Artivion (NYSE:AORT) Rating Lowered to Sell at Wall Street Zen - MarketBeat
ARTIVION, INC. SEC Filing (Aug 14, 2026) - Stock Titan
AORT (AORT) investor files to sell 616 shares after 44,001-share sale - Stock Titan
Artivion (AORT): Nomura entities report 6.5% beneficial stake in 13G/A - Stock Titan
Artivion Inc (AORT) SVP and General Counsel Jean Holloway Sells 977 Shares - GuruFocus
Artivion SVP Jean Holloway sells 977 shares for $27,834 By Investing.com - Investing.com India
Jean Holloway Sells 977 Shares of Artivion (NYSE:AORT) Stock - MarketBeat
Artivion at canaccord growth conference: pipeline drives growth plan By Investing.com - Investing.com Canada
Artivion at canaccord growth conference: pipeline drives growth plan - Investing.com
Artivion SVP Jean Holloway sells 977 shares for $27,834 - Investing.com
Artivion (AORT) Is Up 5.5% After FDA AMDS Approval And Reaffirmed 2026 Revenue GuidanceWhat's Changed - simplywall.st
Artivion, Inc. (AORT) Stock Price, News, Quote & History - ca.finance.yahoo.com
Can Artivion (NYSE:AORT) Gain Ground on the NYSE Composite? - Kalkine Media
Artivion (NYSE:AORT) Stock Price Up 8.2%What's Next? - MarketBeat
Artivion, Inc. (AORT) Stock Analysis: Strong Buy Ratings Signal Potential Upside of Nearly 60% - DirectorsTalk Interviews
Artivion, Inc. (AORT) stock price, news, quote and history - Yahoo Finance UK
Artivion revenue up 11% to USD 125.8M in Q2 2026 - Medical Buyer
Artivion Inc (AORT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Artivion (AORT) and Globus Medical (GMED) - The Globe and Mail
Artivion (AORT) Stock Can Revenue Growth Outrun Fresh Losses? - Sahm
Canaccord raises Artivion stock price target on acquisition, PMA approval By Investing.com - Investing.com South Africa
Artivion Q2 Earnings Call Highlights - MarketBeat
Artivion Announces Q2 2026 Financial Results: Revenue Increase and Net Loss Amid Endospan Acquisition - Kalkine Media
ARTIVION, INC. 2026: Revenue $125.76M, EPS ($0.28) — 10-Q Summary - TradingView
Long-Term Growth Opportunities Remain for Artivion (AORT) Despite Challenges - Yahoo Finance
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $38 to $45 - Moomoo
Artivion Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Canaccord raises Artivion stock price target on acquisition, PMA approval - Investing.com
Earnings call transcript: Artivion tops Q2 2026 revenue forecast as shares rise - Investing.com Australia
Artivion Inc (AORT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.04%
자본화:
|
볼륨(24시간):